Optimization of formulation and process variable of nanosuspension: An industrial perspective

International Journal of Pharmaceutics

Volumn 402, Issue 1-2, 2010, Pages 213-220

  Singare, Dhananjay S ^a,d   Marella, Seshasai ^a   Gowthamrajan, K ^b   Kulkarni, Giriraj T ^c   Vooturi, Rajesh ^a   Rao, Parchuri Srinivasa ^a  

^a DR REDDY'S LABORATORIES LTD   (India)

^b JSS COLLEGE OF PHARMACY   (India)

^c Maratha Mandal's College of Pharmacy   (India)

^d Karpagam College of Pharmacy   (India)

Author keywords

Analysis of variance (ANOVA); Bead mill; Box Behnken design; Nanosuspension; Particle size distribution d(90); Zeta potential

Indexed keywords

DODECYL SULFATE SODIUM; HYDROXYPROPYLMETHYLCELLULOSE; MELOXICAM; NANOPARTICLE;

ARTICLE; DRUG FORMULATION; DRUG MANUFACTURE; MICROFLUIDIC ANALYSIS; PARTICLE SIZE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RESPONSE SURFACE METHOD; SUSPENSION; X RAY DIFFRACTION; ZETA POTENTIAL;

ANALYSIS OF VARIANCE; DRUG CARRIERS; DRUG DESIGN; DRUG INDUSTRY; NANOPARTICLES; NANOTECHNOLOGY; PARTICLE SIZE; POLYMERS; SURFACE-ACTIVE AGENTS; SUSPENSIONS; THIAZINES; THIAZOLES; TIME FACTORS;

EID: 78349309563     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.09.041     Document Type: Article

References (7)

1. Date A.A., Patravale V.B. Current strategies for engineering drug nanoparticles. Curr. Opin. Colloid Interface Sci. 2004, 9:222-235.
2. Kesisoglou F., Panmai S., Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 2007, 59:631-644.
3. Liversidge G., Ruddy S.B., 2009. Will nanoparticles deliver? http://www.dddmag.com/Article-Nanoparticles-For-Drug-Delivery-050509.aspx.
4. Muller R.H., Jacobs C., Kayser O. Nanosuspensions as particulate drug formulations in therapy Rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 2001, 47:3-19.
5. Raval J.A., Patel J.K., Patel M.M. Nanosuspensions as Particulate Drug Delivery Systems 2006, vol. 4. http://www.pharmainfo.net/reviews/.
6. Verma S., Lanb Y., Gokhale R., Burgess D.J. Quality by design approach to understand the process of nanosuspension preparation. Int. J. Pharm. 2009, 377:185-198.
7. Zidan A.S., Sammour O.A., Hammad M.A., Megrab N.A., Habib M.J., Khan M.A. Quality by design: Understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function. Int. J. Pharm. 2007, 332:55-63.